Across TCGA pan-cancer cohorts, LINC01182 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC01182 data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC01182 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01182 expression acts as an unfavorable survival marker, although some lineages such as LGG and ACC show a favorable association.
KIRC, LGG, and CHOL are the cancer types where LINC01182 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.